COMPANY
Milagen
Milagen is a private diagnostic company with a product portfolio for cancer care (early detection of cancer recurrence and for the monitoring of therapy efficacy in real time) and the early detection of cancer for a wide population screening of asymptomatic individuals over 45 years. From company website Source · Oct 12, 2026
NIH awards 5
- NIH award 5R44CA124166-03 FY2009: $440,097 awarded for that fiscal year; activity R44 (SBIR); PI VALLE, ROSAURA P.C.; recipient as written: MILAGEN, INC., EMERYVILLE, CA. Serum-based assays for pancreatic cancer dete source ↗
- NIH award 1R43CA137921-01 FY2008: $141,458 awarded for that fiscal year; activity R43 (SBIR); PI CHAVANY, CHRISTINE; recipient as written: MILAGEN, INC., EMERYVILLE, CA. Novel immunodiagnostic assays for colorectal c source ↗
- NIH award 2R44CA124166-02 FY2008: $400,912 awarded for that fiscal year; activity R44 (SBIR); PI VALLE, ROSAURA P.C.; recipient as written: MILAGEN, INC., EMERYVILLE, CA. Serum-based assays for pancreatic cancer dete source ↗
- NIH award 1R43CA124166-01 FY2006: $99,684 awarded for that fiscal year; activity R43 (SBIR); PI VALLE, ROSAURA P.C.; recipient as written: MILAGEN, INC., EMERYVILLE, CA. Serum-based assays for pancreatic cancer detec source ↗
- NIH award 1R43DK070359-01A1 FY2005: $143,460 awarded for that fiscal year; activity R43 (SBIR); PI CHAVANY, CHRISTINE; recipient as written: MILAGEN, INC., EMERYVILLE, CA. Serum biomarker discovery in early onset typ source ↗